JS BIOFUTURE INVEST ApS: Financial statements 2025
CVR: 31080983
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
JS BIOFUTURE INVEST ApS (CVR 31080983) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -18,598 and a net result of DKK 1,492,381 compared with DKK -8,609 the year before. Equity in the 2025 report amounted to DKK 1,706,887. The solvency ratio was 99%.
- Gross Profit
- DKK -18,598
- Profit/Loss
- DKK 1,492,381
- Equity
- DKK 1,706,887
- Total Assets
- DKK 1,724,262
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -19K | 1.5M | 1.7M | 0 |
| 2024 | - | -19K | -9K | 215K | 1 |
| 2023 | - | -15K | -24K | 223K | - |
| 2022 | - | -14K | -5K | 247K | 0 |
| 2021 | - | -66K | -45K | 252K | - |
Official annual report
How creditworthy is JS BIOFUTURE INVEST ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
JS BIOFUTURE INVEST ApS has published its annual report for 2024. Gross profit came to DKK -19,100, and the net result was DKK -8,609.
About JS BIOFUTURE INVEST ApS
JS BIOFUTURE INVEST ApS is a Danish company of the type Anpartsselskab based in Kgs.Lyngby, founded in 2007. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named ApS KBUS 17 NR. 6222. The management consists of Jørgen Schøller. The company is owned by Jørgen Schøller and Anna Carina Wiborg Simonsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,598 and a net result of DKK 1,492,381 compared with DKK -8,609 the year before. Equity in the 2025 report amounted to DKK 1,706,887.